The present invention provides for recombinant monoclonal antibodies that bindto human colorectal andpancreatic carcinoma-associated antigens, along with nucleic acid sequencesencoding the antibody chains, and the amino acid sequencescorresponding to the nucleic acids, and uses for these antibodies, nucleicacids and amino acids.